Overview on Hepatitis B vaccination | ||
| The Egyptian Journal of Hospital Medicine | ||
| Article 112, Volume 86, Issue 1, January 2022, Pages 696-699 PDF (619.35 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhm.2022.215573 | ||
| Authors | ||
| Mona Ali Saber* ; Hatem Abdul-Monsef Sarhan; Yasser Mahrous Fouad; Mahmoud MA Elsayed; Alshymaa Ahmed Hassnine | ||
| Abstract | ||
| Background: Hepatitis B virus (HBV) infection is increasing globally, posing a serious public health problem. Hepatitis B virus (HBV) infection and mortality are among the leading causes of death worldwide. Concerns for public health are amplified by the fact that about a third of the world's population is afflicted with HBV. HBV infection may result in cirrhosis, hepatocellular cancer, or both (HCC). Immunization is the most cost-effective strategy available worldwide for controlling and preventing hepatitis B in terms of benefit-cost ratio. Objective: This review article discusses the most critical components of the HBV vaccine and the most efficient strategies for increasing HBV vaccination. | ||
| Keywords | ||
| Antibodies; HBs-antigen; Hepatitis B vaccine; Hepatitis B virus; Immunizat | ||
|
Statistics Article View: 390 PDF Download: 434 |
||
